144 related articles for article (PubMed ID: 36733053)
21. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients.
Tian P; Zhang X; Yang S; Fang Y; Yuan H; Li W; Zhu H; Zhao F; Ding J; Zhu Y; Wang S; Sun G; Ni H; Ma T; Lei T
J Genet Genomics; 2022 Jul; 49(7):645-653. PubMed ID: 35033608
[TBL] [Abstract][Full Text] [Related]
22. What Should a Gynecologist Know about Li-Fraumeni Syndrome? Lessons from a Patient Undergoing Hysterectomy for Benign Indications.
Advolodkina P; Lachiewicz MP; Oprea-Ilies G; Majmudar B; Gordon AN
Gynecol Obstet Invest; 2018; 83(4):410-414. PubMed ID: 29945152
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Li-Fraumeni syndrome and Li-Fraumeni-like families for germline mutations in Bcl10.
Stone JG; Eeles RA; Sodha N; Murday V; Sheriden E; Houlston RS
Cancer Lett; 1999 Dec; 147(1-2):181-5. PubMed ID: 10660104
[TBL] [Abstract][Full Text] [Related]
24. Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.
Id Said B; Kim H; Tran J; Novokmet A; Malkin D
Hum Mutat; 2016 Sep; 37(9):889-92. PubMed ID: 27297285
[TBL] [Abstract][Full Text] [Related]
25. Association of germline or somatic TP53 missense mutation with oncogene amplification in tumors developed in patients with Li-Fraumeni or Li-Fraumeni-like syndrome.
Sugawara W; Arai Y; Kasai F; Fujiwara Y; Haruta M; Hosaka R; Nishida K; Kurosumi M; Kobayashi Y; Akagi K; Kaneko Y
Genes Chromosomes Cancer; 2011 Jul; 50(7):535-45. PubMed ID: 21484931
[TBL] [Abstract][Full Text] [Related]
26. A case of late-onset Li-Fraumeni-like syndrome with unilateral breast cancer.
Cho Y; Kim J; Kim Y; Jeong J; Lee KA
Ann Lab Med; 2013 May; 33(3):212-6. PubMed ID: 23667851
[TBL] [Abstract][Full Text] [Related]
27. Upper Gastrointestinal Cancer Risk and Surveillance Outcomes in Li-Fraumeni Syndrome.
Katona BW; Powers J; McKenna DB; Long JM; Le AN; Hausler R; Zelley K; Jennings S; Domchek SM; Nathanson KL; MacFarland SP; Maxwell KN
Am J Gastroenterol; 2020 Dec; 115(12):2095-2097. PubMed ID: 32969947
[TBL] [Abstract][Full Text] [Related]
28. Genetic counseling can influence the course of a suspected familial cancer syndrome patient: from a case of Li-Fraumeni like syndrome with a germline mutation in the TP53 gene.
Hwang SM; Lee ES; Shin SH; Kong SY
Korean J Lab Med; 2008 Dec; 28(6):493-7. PubMed ID: 19127115
[TBL] [Abstract][Full Text] [Related]
29. An update on the central nervous system manifestations of Li-Fraumeni syndrome.
Orr BA; Clay MR; Pinto EM; Kesserwan C
Acta Neuropathol; 2020 Apr; 139(4):669-687. PubMed ID: 31468188
[TBL] [Abstract][Full Text] [Related]
30. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
[TBL] [Abstract][Full Text] [Related]
31. Frequency of Radiation Therapy-Induced Malignancies in Patients With Li-Fraumeni Syndrome and Early-Stage Breast Cancer and the Influence of Radiation Therapy Technique.
Petry V; Bonadio RC; Moutinho K; Leite LS; Testa L; Cohn DJBH; Cagnacci AC; Kim VEH; Del Pilar Estevez-Diz M; Fragoso MCBV
Int J Radiat Oncol Biol Phys; 2024 Jul; 119(4):1086-1091. PubMed ID: 38309330
[TBL] [Abstract][Full Text] [Related]
32. Reducing Fatty Acid Oxidation Improves Cancer-free Survival in a Mouse Model of Li-Fraumeni Syndrome.
Wang PY; Ma J; Li J; Starost MF; Wolfgang MJ; Singh K; Pirooznia M; Kang JG; Hwang PM
Cancer Prev Res (Phila); 2021 Jan; 14(1):31-40. PubMed ID: 32958587
[TBL] [Abstract][Full Text] [Related]
33. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
[TBL] [Abstract][Full Text] [Related]
34. Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
Sorrell AD; Espenschied CR; Culver JO; Weitzel JN
Mol Diagn Ther; 2013 Feb; 17(1):31-47. PubMed ID: 23355100
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
[TBL] [Abstract][Full Text] [Related]
36. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
[TBL] [Abstract][Full Text] [Related]
37. Pediatric pituitary adenoma and medulloblastoma in the setting of p53 mutation: case report and review of the literature.
Birk H; Kandregula S; Cuevas-Ocampo A; Wang CJ; Kosty J; Notarianni C
Childs Nerv Syst; 2022 Sep; 38(9):1783-1789. PubMed ID: 35254474
[TBL] [Abstract][Full Text] [Related]
38. Transmission of a
Cotter JA; Szymanski L; Karimov C; Boghossian L; Margol A; Dhall G; Tamrazi B; Varaprasathan GI; Parham DM; Judkins AR; Biegel JA
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29581140
[TBL] [Abstract][Full Text] [Related]
39. Nodular Lymphocyte-predominant Hodgkin Lymphoma in a 15-Year-Old Boy With Li-Fraumeni Syndrome Having a Germline TP53 D49H Mutation.
Yamazaki F; Shima H; Osumi T; Narumi S; Kuroda T; Shimada H
J Pediatr Hematol Oncol; 2018 Apr; 40(3):e195-e197. PubMed ID: 28902083
[TBL] [Abstract][Full Text] [Related]
40. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Kamihara J; Rana HQ; Garber JE
Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]